•Pfizer received FDA approval to expand the use of its drug Hympavzi to additional hemophilia A and B patient groups, including children with inhibitors.
•A bipartisan pair of U.S. senators urged the Trump administration to tighten rules on contract chipmakers like TSM to prevent them from making advanced AI chips for overseas units of Chinese firms.
•Japan's Inpex announced it will seek urgent orders from Australia's Fair Work Commission to stop protected industrial action at its Ichthys LNG facilities.
